EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Interferon-Based Therapeutics in Cancer Therapy: Past, Present, and Future

Kristina Vorona iD, Anastasia Ryapolova iD, Olesya Sokolova iD, Alexander Karabelsky iD, Roman Ivanov iD, Vasiliy Reshetnikov iD, Ekaterina Minskaia iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262311679 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Kristina Vorona und 6 weiteren Autor:innen. Beteiligte Einrichtung: Translational Medicine Research Center, Sirius University of Science and Technology, 1 Olympic Avenue, 354340 Sochi, Russia. Hauptthemen laut MEDLINE: Neoplasms, Interferons, Antineoplastic Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 226 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: State program of the "Sirius" Federal Territory "Scientific and technological development of the "Sirius" Federal Territory", State program of the “Sirius” Federal Territory “Scientific and technological development of the “Sirius” Federal Territory”.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interferons (IFNs) are well-known immunostimulants involved in both innate and adaptive immune responses. These multifunctional proteins mediate an early antiviral response and have pronounced immunomodulatory and antiproliferative properties. Due to their potency, IFNs have been used not only in the treatment of viral infections but also various other diseases. However, the use of IFNs in antitumor therapy has been limited by the frequent severe side effects, which reduced their appeal for the treatment of cancer. In this review, we focused on current data on recombinant IFNs used for anticancer therapy, as well as the development of promising IFN-based gene therapy approaches, with a focus on their safety and therapeutic efficacy. We also highlighted various types of IFNs and their application niches in the treatment of not only cancers in combination therapy but also of certain rare diseases. Taken together, this review improves our understanding of the existing IFN applications in cancer therapy, the disadvantages of using IFNs, and possible approaches for their improvement.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsInterferonsAntineoplastic AgentsHumansAnimalsGenetic Therapy

Stichwörter der Autor:innen

IFNanti-cancer therapyantitumor therapyinterferoninterferon type

Substanzen

InterferonsAntineoplastic Agents

Autor:innen und Institutionen

  • Translational Medicine Research Center, Sirius University of Science and Technology, 1 Olympic Avenue, 354340 Sochi, Russia.

ORCID-Profile: Kristina Vorona, Anastasia Ryapolova, Olesya Sokolova, Alexander Karabelsky, Roman Ivanov, Vasiliy Reshetnikov, Ekaterina Minskaia

Förderung

  • State program of the "Sirius" Federal Territory "Scientific and technological development of the "Sirius" Federal Territory"
  • State program of the “Sirius” Federal Territory “Scientific and technological development of the “Sirius” Federal Territory”

Zitieren

APA

Vorona, K., Ryapolova, A., Sokolova, O., Karabelsky, A., Ivanov, R., Reshetnikov, V., & Minskaia, E. (2025). Interferon-Based Therapeutics in Cancer Therapy: Past, Present, and Future. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262311679

Vancouver

Vorona K, Ryapolova A, Sokolova O, Karabelsky A, Ivanov R, Reshetnikov V, et al. Interferon-Based Therapeutics in Cancer Therapy: Past, Present, and Future. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262311679

BibTeX
@article{Vorona2025,
  author = {Vorona, Kristina and Ryapolova, Anastasia and Sokolova, Olesya and Karabelsky, Alexander and Ivanov, Roman and Reshetnikov, Vasiliy and Minskaia, Ekaterina},
  title = {Interferon-Based Therapeutics in Cancer Therapy: Past, Present, and Future},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262311679}
}
Kostenlos starten →